BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34144098)

  • 1. The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2).
    da Costa V; van Vliet SJ; Carasi P; Frigerio S; García PA; Croci DO; Festari MF; Costa M; Landeira M; Rodríguez-Zraquia SA; Cagnoni AJ; Cutine AM; Rabinovich GA; Osinaga E; Mariño KV; Freire T
    Cancer Lett; 2021 Oct; 518():72-81. PubMed ID: 34144098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties.
    Costa VD; Mariño KV; Rodríguez-Zraquia SA; Festari MF; Lores P; Costa M; Landeira M; Rabinovich GA; van Vliet SJ; Freire T
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL).
    van Vliet SJ; Vuist IM; Lenos K; Tefsen B; Kalay H; García-Vallejo JJ; van Kooyk Y
    J Biol Chem; 2013 Sep; 288(38):27519-27532. PubMed ID: 23918927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.
    Freire T; Zhang X; Dériaud E; Ganneau C; Vichier-Guerre S; Azria E; Launay O; Lo-Man R; Bay S; Leclerc C
    Blood; 2010 Nov; 116(18):3526-36. PubMed ID: 20720186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.
    Tumoglu B; Keelaghan A; Avci FY
    Glycobiology; 2023 Dec; 33(11):879-887. PubMed ID: 37847609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells.
    Denda-Nagai K; Aida S; Saba K; Suzuki K; Moriyama S; Oo-Puthinan S; Tsuiji M; Morikawa A; Kumamoto Y; Sugiura D; Kudo A; Akimoto Y; Kawakami H; Bovin NV; Irimura T
    J Biol Chem; 2010 Jun; 285(25):19193-204. PubMed ID: 20304916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen.
    Gabba A; Bogucka A; Luz JG; Diniz A; Coelho H; Corzana F; Cañada FJ; Marcelo F; Murphy PV; Birrane G
    Biochemistry; 2021 May; 60(17):1327-1336. PubMed ID: 33724805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties.
    Singh SK; Streng-Ouwehand I; Litjens M; Weelij DR; García-Vallejo JJ; van Vliet SJ; Saeland E; van Kooyk Y
    Mol Immunol; 2009 Mar; 46(6):1240-9. PubMed ID: 19162326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
    Gabba A; Attariya R; Behren S; Pett C; van der Horst JC; Yurugi H; Yu J; Urschbach M; Sabin J; Birrane G; Schmitt E; van Vliet SJ; Besenius P; Westerlind U; Murphy PV
    J Am Chem Soc; 2023 Jun; 145(24):13027-13037. PubMed ID: 37279388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.
    Napoletano C; Zizzari IG; Rughetti A; Rahimi H; Irimura T; Clausen H; Wandall HH; Belleudi F; Bellati F; Pierelli L; Frati L; Nuti M
    Eur J Immunol; 2012 Apr; 42(4):936-45. PubMed ID: 22531918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
    Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
    PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Tn-Antigen-Positive Human Tumors with a Recombinant Human Macrophage Galactose C-Type Lectin.
    Bulteau F; Thépaut M; Henry M; Hurbin A; Vanwonterghem L; Vivès C; Le Roy A; Ebel C; Renaudet O; Fieschi F; Coll JL
    Mol Pharm; 2022 Jan; 19(1):235-245. PubMed ID: 34927439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
    Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MGL2 Dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo.
    Kumamoto Y; Denda-Nagai K; Aida S; Higashi N; Irimura T
    PLoS One; 2009; 4(5):e5619. PubMed ID: 19440334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
    Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
    Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses.
    Singh SK; Streng-Ouwehand I; Litjens M; Kalay H; Saeland E; van Kooyk Y
    Int J Cancer; 2011 Mar; 128(6):1371-83. PubMed ID: 20473945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.
    Song NY; Li X; Ma B; Willette-Brown J; Zhu F; Jiang C; Su L; Shetty J; Zhao Y; Shi G; Banerjee S; Wu X; Tran B; Nussinov R; Karin M; Hu Y
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35121655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophage Gal/GalNAc lectin 2 (MGL2)
    Costa M; da Costa V; Lores P; Landeira M; Rodríguez-Zraquia SA; Festari MF; Freire T
    Sci Rep; 2022 Oct; 12(1):17661. PubMed ID: 36271272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.